Higher Starting Dose and Rapid Attainment of Tacrolimus Blood Levels With Envarsus Vs. Prograf Is Not Associated With Increased Toxicity: Exploratory Analysis of a Phase 3, Double-Blind, Double-Dummy, Multi-Center, Randomized, Prospective Study of Envarsus (Once-Daily MeltDose Tacrolimus Tablets) Vs. Prograf (Twice-Daily Tacrolimus Capsules)

被引：0

作者：

Tedesco Silva, H., Jr. ^{[1
]}

Bunnapradist, S. ^{[2
]}

Steinberg, S. ^{[3
]}

机构：

[1] Hosp Rim, Sao Paulo, Brazil

[2] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA

[3] Calif Inst Renal Res, San Diego, CA USA

来源：

TRANSPLANTATION | 2014年 / 98卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

A207

引用

页码：458 / 458

页数：1

共 16 条

[1] Higher Starting Dose and Rapid Attainment of Tacrolimus Blood Levels With Envarsus Vs. Prograf Is Not Associated With Increased Toxicity: Exploratory Analysis of a Phase 3, Double-Blind, Double-Dummy, Multi-Center, Randomized, Prospective Study of Envarsus (Once-Daily MeltDose Tacrolimus Tablets) Vs. Prograf (Twice-Daily Tacrolimus Capsules).
Silva, H. Tedesco, Jr.
Bunnapradist, S.
Steinberg, S.
AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 458 - 458
[2] Two-Year Results of Envarsus (Once-Daily MeltDose Tacrolimus Tablets) vs Prograf (Twice-Daily Tacrolimus Capsules): A Phase 3, Double-Blind, Double-Dummy, Multi-Center, Prospective, Randomized Study
Rostaing, L.
Ciechanowski, K.
Bunnapradist, S.
Silva, H., Jr.
Grinyo, J.
Budde, K.
TRANSPLANTATION, 2014, 98 : 661 - 662
[3] Two-Year Results of Envarsus (Once-Daily MeltDose Tacrolimus Tablets) vs Prograf (Twice-Daily Tacrolimus Capsules): A Phase 3, Double-Blind, Double-Dummy, Multi-Center, Prospective, Randomized Study.
Rostaing, L.
Ciechanowski, K.
Bunnapradist, S.
Silva, H., Jr.
Grinyo, J.
Budde, K.
AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 661 - 662
[4] Higher Initial Exposure of Envarsus Immediately Post Transplantation Is Not Associated With Increased Risk of Delayed Graft Function in Kidney Transplant Patients Treated With Novel Once-Daily MeltDose Tacrolimus (Envarsus) Vs. Twice-Daily Tacrolimus (Prograf): Results From a Phase 3, Double-Blind, Double-Dummy, Multi-Center, Randomized Trial
Budde, K.
Silva, H.
Steinberg, S.
Kamar, N.
AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 460 - 460
[5] Higher Initial Exposure of Envarsus Immediately Post Transplantation Is Not Associated With Increased Risk of Delayed Graft Function in Kidney Transplant Patients Treated With Novel Once-Daily MeltDose Tacrolimus (Envarsus) Vs. Twice-Daily Tacrolimus (Prograf): Results From a Phase 3, Double-Blind, Double-Dummy, Multi-Center, Randomized Trial
Budde, K.
Silva, H.
Steinberg, S.
Kamar, N.
TRANSPLANTATION, 2014, 98 : 460 - 460
[6] POOLED ANALYSIS TO EXAMINE THE PK AND SAFETY OF ONCE-DAILY EXTENDED-RELEASE MELTDOSE® TACROLIMUS TABLETS (ENVARSUS®) VS. TWICE-DAILY TACROLIMUS (PROGRAF®) IN DE NOVO KIDNEY AND LIVER TRANSPLANTATION
Mulgaonkar, Shamkant
Dubay, Derek
Bunnapradist, Suphamai
TRANSPLANT INTERNATIONAL, 2015, 28 : 202 - 202
[7] Lipid Profiles Over 2 Years Follow-Up in De Novo Kidney Transplant Recipients Randomized to Once-Daily MeltDose® Tacrolimus (Envarsus® XR) Vs. Twice-Daily Tacrolimus (Prograf®): Results from a Phase 3, Double-Blind, Double-Dummy, Multicenter Trial
Mulgaonkar, S.
Pankewycz, O.
Steinberg, S.
AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
[8] Improved Bioavailability and Reduced Dose Requirements of Novel, Once-Daily, MeltDose® Tacrolimus Formulation Tablets (Envarsus® XR) Compared to Twice-Daily Tacrolimus Capsules (Prograf®) in De Novo Kidney Transplantation: Results of a Phase 3 Double-Dummy, Randomized Trial
Grinyo, J.
Bunnapradist, S.
Mulgaonkar, S.
Steinberg, S.
AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
[9] Efficacy, Safety and Pharmacokinetics of Once-Daily, MeltDose® Tacrolimus (Envarsus® XR) Versus Twice-Daily Tacrolimus (Prograf®) in De Novo Kidney Transplant Recipient Sub-Groups: A 2 Year Phase 3 Randomized, Double-Blind, Double-Dummy, Trial
Bunnapradist, S.
Denny, J.
Waybill, M.
West-Thielke, P.
Steinberg, S.
AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
[10] IMPROVED BIOAVAILABILITY AND REDUCED DOSE REQUIREMENTS OF ENVARSUS®, NOVEL ONCE-DAILY, MELTDOSE® TACROLIMUS FORMULATION COMPARED TO PROGRAF® (TAC BID, TWICE-DAILY TACROLIMUS), IN DE NOVO KIDNEY TRANSPLANTATION (KTR) PATIENTS: RESULTS OF A PHASE 3 DOUBLE-DUMMY, RANDOMIZED TRIAL
Albano, L.
Rostaing, L.
TRANSPLANT INTERNATIONAL, 2016, 29 : 9 - 9

← 1 2 →